Bio-Matrix Scientific Group Inc (BMSN) 0.0002

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bio-Matrix Scientific Group Inc (BMSN) 0.0002 $BMSN

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019
M2 - Thu Apr 23, 9:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z5h992/regenerative) has announced the addition of the "Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019" report to their offering. Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017, growing at a CAGR of 12.2% for the analysis period 2013-2019 respectively. Skin/Integumentary and Urology together account for approximately 25.97% (2016) of the market are expected to support the Regenerative Medicine Industry going forward. Geographical analysis for Regenerative Medicine in Cardiology shows that the highest Compounded Annual Growth Rate (CAGR) of 18.1% is anticipated from Asia-Pacific region during the analysis period 2013-2019. The report Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019' reviews the latest trends in regenerative medicine with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. Regenerative Medicine - Segmentation - Therapeutic Area - Orthopedics - Skin/Integumentary - Cardiology - Neurology - Urology - Other - Biological Substitutes - Cells and Biomaterials - Biomolecules - Manufacturing Factors and - Other Companies Mentioned The Americas - Cell2B (USA) - Angiocrine Bioscience (USA) - Platelet Biogenesis (USA) - Biomatrica, Inc (USA) - Athersys, Inc. (USA) - Cellular Dynamics International, Inc. (USA) - Tengion Inc (USA) - Vericel Corporation (USA) - Wright Medical Technology (USA) - Tissuegene, Inc. (USA) - Shire Regenerative Medicine (USA) - Regen Biopharma (Bio-Matrix Scientific Group) (USA) - Dsm Biomedical (USA) - Harvard Apparatus Regenerative Technology (USA) Europe - Cellserve Gmbh (Germany) - Trakcel Ltd (United Kingdom) - Crispr Therapeutics (Switzerland) Asia-Pacific - Cytori Therapeutics Inc (Japan) - Cyfuse Biomedical Kk (Japan) - Regenovo Biotechnology (China) - Cynata Therapeutics Limited (Australia) For more information visit http://www.researchandmarkets.com/research/z5...generative
VCEL: 2.26 (+0.01), ICEL: 16.55 (+0.03), CYTX: 2.09 (unch), ATHX: 2.22 (+0.05)

Regen BioPharma Scheduled to Make Presentation at American Society for Hematology's 56th Annual Meeting in San Francisco December 6th - 9th
Marketwired - Mon Dec 01, 7:30AM CST
Regen BioPharma (OTCBB: RGBP) announced today acceptance by the American Society for Hematology of a presentation by Christine Ichim, PhD, senior scientific research consultant to Regen BioPharma, at its annual meeting entitled "NR2F6 (EAR-2) Is a Novel Leukemia Oncogene Whose Cellular Function Is to Regulate Terminal Differentiation of Erythrocytes at the Proerythroblast Stage." The work will be presented on Saturday December 6, 2014 at the West Building, Level 1 in the Moscone Center, San Francisco at 5:30 PM.

Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property
Marketwired - Tue Nov 25, 7:30AM CST
Regen BioPharma Inc. (OTCBB: RGBP) announced today acquisition of patent application # US 13/652,395 with a priority date of November 2008 which covers a novel gene target essential for the survival of cancer stem cells. Inventors of the intellectual property on which this patent application was filed are University of Toronto Hematologist Dr. Richard Wells and Dr. Christine Ichim, Senior Research Consultant for Regen BioPharma.

FDA Issues IND Number for Regen BioPharma's dCellVax Therapeutic Application, a Proposed Treatment for Breast Cancer
Marketwired - Tue Nov 04, 7:31AM CST
Regen BioPharma, Inc. (OTCBB: RGBP) announced today issuance of IND (Investigational New Drug Application) number 16200 from the FDA for a proposed Phase I/II clinical trial assessing safety with signals of efficacy of the dCellVax gene silenced dendritic cell immunotherapy for treating breast cancer.

Regen BioPharma's Chief Scientific Officer Examines Potential Role of Immunotherapeutic Treatment for Ebola in Conjunction With Other Current Therapies
Marketwired - Tue Oct 28, 8:05AM CDT
Regen BioPharma Inc.'s (OTCBB: RGBP) Chief Scientific Officer Dr. Thomas Ichim stated today that The Company is currently identifying potential immunotherapeutic treatments that might have value in treating some of the effects of Ebola in conjunction with other treatments. The goal of using immunotherapy in mitigating some of the side effects of Ebola is to jump start the body's own immune system to identify and fight off these potentially fatal conditions.

Regen BioPharma Inc. Files IND Application With FDA for dCellVax Breast Cancer Immune Therapy
Marketwired - Wed Oct 08, 11:29AM CDT
Regen BioPharma Inc. (OTCBB: RGBP) announced today the filing of an Investigational New Drug (IND) application to the United States Food and Drug Administration (FDA) to initiate a clinical trial assessing safety and therapeutic effects of dCellVax in patients with metastatic breast cancer. dCellVax is an immunotherapeutic product that utilizes the patient's own immune cells to attack the tumor. Success of dCellVax in the proposed trial is anticipated to pave the way for expanded use of dCellVax in a variety of other tumors. Advantages of cancer immune therapies include: a) lack of toxicity; b) ability to attack tumor metastasis; and c) generation of immunological memory, which protects the body from recurrence of the tumor.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 231

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 417

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 211

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 193

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 207

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 249

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 432

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 286

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 196

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 367

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading

Top 5 Most Recently Viewed Articles

StorageVault Canada Inc. Declares Q4 Dividend for Stakeholders

Updated Category News Views 91

StorageVault Canada Inc. Declares Q4 Dividend Announcement In a recent announcement, StorageVault Canada Inc. (TSX: SVI) revealed a quarterly dividend of $0.002991 per common share. This dividend is set to be distributed on January 15, 2026, to all shareholders listed as of December 31, 2025, coinciding with the ex-dividend date also on December 31. This designation...

Continue Reading
Calm Tuesday for Major Cryptocurrencies: Insights and Updates

Updated Category News Views 165

Market Overview: Cryptocurrencies in Focus On a quieter Tuesday, major cryptocurrencies such as Bitcoin, Ethereum, and XRP are showing a notable degree of stability. Bitcoin is currently trading just below $87,000 as it contends with the influx of new altcoin spot ETFs entering the market. Key Price Movements As investors navigate the changing landscape, here are the...

Continue Reading
Current Legal Challenge for Sun Communities, Inc. Investors

Updated Category News Views 286

Understanding the Sun Communities, Inc. Class Action Recently, a significant alert regarding Sun Communities, Inc. has been brought to attention for its stockholders. A class action has been initiated against the company due to allegations of misleading investors about possible conflicts of interest. Sun Communities, Inc. (SUI), primarily recognized for its investments in...

Continue Reading
Seeking Justice: BHC Sierra Vista Hospital Faces Allegations

Updated Category News Views 368

Labor Law Violation Allegations Against BHC Sierra Vista Hospital BHC Sierra Vista Hospital, Inc. is currently facing serious allegations for failing to provide its employees with legally mandated meal and rest breaks during their shifts. This alleged neglect not only goes against the California Labor Code but also contributes to the unfortunate situation where employees...

Continue Reading
ZKH Group Limited Reports Q3 2025 Financial Performance Insights

Updated Category News Views 183

Overview of ZKH Group Limited's Financial Results ZKH Group Limited (NYSE: ZKH), a premier platform for maintenance, repair, and operations (MRO) procurement services, has announced its unaudited financial results for the third quarter of 2025. The company has shown resilience and adaptability amidst a challenging economic landscape, with significant operational...

Continue Reading